Nderipi gomarara raizobatsirikana nekubatanidza Ashtaba mukudya kwavo?

Muchidimbu

Ashitaba inozivikanwa zvakanyanya nekuda kwehutano hwayo uye inowanzoshandiswa nevarwere vegomarara nevaya vari panjodzi yemagene. Asi, kuchengetedzeka uye kushanda kweAshitaba yevarwere vegomarara kunoenderana nezvinhu zvakawanda senge chiratidzo chegomarara, chemotherapy, kumwe marapirwo, uye genetics yebundu. Kuziva kuti zvimwe zvekudya uye zvekuwedzera, senge mazambiringa uye sipinachi, zvinogona kudyidzana zvisina kunaka nemishonga yekenza uye kukonzera kusawirirana kwakakosha.

Kudya kwakakosha pakurapwa kenza nekuti kunogona kukanganisa mhedzisiro yekurapa. Varwere vegomarara vanofanira kunyatsosarudza uye nekubatanidza chikafu chakakodzera uye chekuwedzera mukudya kwavo. Semuenzaniso, Ashitaba inogona kubatsira avo vane Primary Penile Squamous Cell Carcinoma vari pasi peMitomycin, asi zvingasava zvakanaka kune varwere vanowana Letrozole yePrimary Paget chirwere chezamu. Uyezve, nepo Ashitaba inogona kubatsira vanhu vane genetic risk factor "ALK", inogona kunge isingafungidzirwe kune avo vane imwe genetic ngozi "ATM". Kugadzirisa zvirongwa zvekudya zvinoenderana nehutano, kurapwa, uye genetics kwakakosha.

Kunzwisisa kuti kuita sarudzo pakukodzera kweAshitaba kune murwere wegomarara kunofanirwa kuve munhu mumwe kwakakosha. Zvinhu zvakakosha serudzi rwegomarara, nzira dzekurapa, genetic makeup, genetic njodzi, zera, uremu hwemuviri, uye mararamiro zvakakosha pakusarudza kana Ashitaba iriyo sarudzo yakakodzera. Genetics uye genomics, kunyanya, inonyanya kutariswa. Sezvo zvinhu izvi zvichigona kushanduka, zvakakosha kuti ugare uchiongorora uye kugadzirisa sarudzo dzekudya kuti dzienderane nekuchinja kwehutano uye kurapwa.

Mukupedzisa, nzira yakasarudzika yesarudzo yekudya yakakosha, kutarisa kune yakazara mhedzisiro yezvinhu zvese zvinoshanda muzvokudya/zvinowedzera zvakaita seAshitaba panzvimbo yekuongorora chimwe nechimwe chinoshandiswa chinoshandiswa zvakasiyana kana kusachifuratira zvachose. Maonero akafara aya anosimudzira nzira inonzwisisika uye yesainzi yekuronga kudya kwegomarara.

Pfupiso Pfupiso

Kushandiswa kwezvikafu zvakadyarwa nezvirimwa uye zvekuwedzera, senge mavhitamini, maruva, zvicherwa, probiotics, uye akasiyana siyana ekuwedzera, ari kuwedzera pakati pevarwere vegomarara. Izvi zvekuwedzera zvakagadzirirwa kuendesa yakakwira yakakwira yeaya anoshanda zvimisikidzo, mazhinji acho ari mukudya kwakasiyana. Iko kusungirirwa uye kusiyanisa kwezvinhu zvinoshanda zvinosiyana pakati pezvikafu zvese uye zvekuwedzera. Zvokudya zvinowanzopa huwandu hwezvinhu zvinoshanda asi pazvishoma zvakadzika, nepo ma supplements achipa huwandu hwepamusoro hwezvimwe zvinhu.

Tichifunga nezveakasiyana esainzi uye biological mabasa ega ega rinoshanda padanho remamorekuru, zvakakosha kuti uzvidavirire kune akasanganiswa mhedzisiro yezvikamu izvi kana uchifunga nezvechikafu uye chekuwedzera chekudya kana kusadya.

Mubvunzo wakaoma unomuka: Iwe unofanirwa here kubatanidza Ashitaba mukudya kwako sechinhu chekudya kana chekuwedzera? Zvinogoneka here kushandisa Ashitaba kana iwe uine genetic predisposition kune cancer yakabatana neiyo ALK gene? Ko kana pachinzvimbo njodzi yako yemajini ichibva kuATM gene? Zvinobatsira here kuisa Ashitaba mukudya kwako kana wabatwa chirwere chePrimary Paget chezamu, kana kuti chirwere chako chiri Primary Penile Squamous Cell Carcinoma? Uyezve, manwiro ako eAshitaba anofanira kugadziriswa sei kana uri kurapwa neMitomycin kana chirongwa chako chekurapa chichibva kuMitomycin kuenda kuLetrozole? Izvo zvakakosha kuti uzive kuti zvirevo zviri nyore senge 'Ashitaba ndezvakasikwa, saka zvinogara zvichibatsira' kana kuti 'Ashitaba inowedzera kusadzivirirwa' hazvina kukwana pasarudzo dzechikafu/yekuwedzera.

Pamusoro pezvo, zvakakosha kuti uongorore zvakare kukodzera kwekubatanidza Ashitaba mukudya kwako kana paine shanduko muchirongwa chako chekurapa. Muchidimbu, kana uchiita sarudzo dzekubatanidza chikafu kana ma supplements seAshitaba mukudya kwako kune zvakanakira, iwe unofanirwa kufunga nezvese biochemical mhedzisiro yezvese zvinongedzo, uchifunga zvinhu zvakaita serudzi rwegomarara, marapirwo chaiwo auri kuita, genetic predispositions. , uye sarudzo dzemararamiro.

kenza

Kenza inoramba iri dambudziko rakakura mune zvekurapa, kazhinji ichikonzera kunetseka kwakapararira. Nekudaro, kufambira mberi kwazvino kwakavandudza marapirwo ekurapa, kunyanya kuburikidza nemaitiro ekurapa emunhu, nzira dzisingapindire dzekutarisa uchishandisa ropa uye mate samples, uye kuvandudzwa kweimmunotherapy. Kuonekwa kwekutanga uye kupindira panguva yakakodzera kwave kwakakosha mukupesvedzera zvakanaka mhedzisiro yekurapa.

Kuongororwa kweGenetic kunopa vimbiso yakakosha mukuongorora njodzi yegomarara uye kukurumidza kutanga. Nekudaro, kune vanhu vazhinji vane mhuri uye genetic predispositions kugomarara, sarudzo dzekupindira kwekurapa, kunyangwe nekutarisa nguva dzose, kazhinji dzinogumira kana hapana. Kana ukangoonekwa uine imwe mhando yegomarara, yakadai sePrimary Penile Squamous Cell Carcinoma kana Primary Paget chirwere chezamu, nzira dzekurapa dzinofanirwa kugadziridzwa zvichienderana nebundu remunhu genetics, danho rechirwere, pamwe nezvinhu zvakaita sezera uye. murume kana mukadzi.”

Mushure mekurapa, kuenderera mberi kwekutarisa kwakakosha kuti uone chero zviratidzo zvekenza kudzoka uye kuzivisa sarudzo dzinotevera. Vazhinji varwere vegomarara uye avo vari panjodzi vanowanzo tsvaga zano rekubatanidza zvimwe zvekudya uye zvekuwedzera mukudya kwavo, izvo zvinotora basa rakakosha mukuita kwavo kwese kwekuita sarudzo maererano nehutano hwehutano.

Mubvunzo wakaoma ndewekuti ungakonzeresa njodzi dzemajini uye negomarara rekuongororwa kana uchifunga nezvesarudzo dzekudya, senge Ashitaba. Ko genetic njodzi yegomarara kubva mukuchinjika muALK ine zvakafanana biochemical nzira nzira sekuchinja muATM? Kubva pane zvinovaka muviri, njodzi inosanganisirwa nePrimary Penile Squamous Cell Carcinoma inofananidzwa nePrimary Paget chirwere chezamu? Uyezve, kufunga kwekudya kunoramba kwakafanana kune avo vari pasi peLetrozole kune avo vanogamuchira Mitomycin? Aya mafungidziro akakosha pakuita sarudzo dzechikafu kune vanhu vane njodzi dzakasiyana dzemajini uye marapirwo egomarara.

Ashitaba – A Nutritional Supplement

Iyo yekuwedzera Ashitaba inosanganisira huwandu hwezvinhu zvinoshanda, zvinosanganisira Isobavachalcone, imwe neimwe iripo panguva dzakasiyana. Izvi zvinongedzo zvinopesvedzera nzira dzemamorekuru, kunyanya Lipid Metabolism, PI3K-AKT-MTOR Kuratidzira uye MAPK Signaling, iyo inoronga zvakakosha zvegomarara padanho remasero, sekukura kwebundu, kupararira, uye kufa kwesero. Tichifunga izvi biological pesvedzero, kusarudza iwo akakodzera ekuwedzera seAshitaba, ari ega kana musanganiswa, inova sarudzo yakakosha mumamiriro ehutano hwegomarara. Paunenge uchifunga kushandisa Ashitaba yegomarara, zvakakosha kuti utarise izvi zvakasiyana zvinhu uye maitiro. Izvi zvinodaro nekuti, zvakafanana nekurapa cancer, kushandiswa kweAshitaba haisi sarudzo yepasirese yakakodzera vese vane cancer asi inoda kuve munhu.

Kusarudza Ashitaba Supplements

Kugadzirisa mubvunzo wekuti 'Ndirini pandinofanira kudzivisa Ashitaba mumamiriro ezvinhu eCancer' zvinonetsa nokuti mhinduro yacho ndeyemunhu oga - zvinongoreva 'Zvinoenderana!'. Zvakafanana nemabatiro ekurapa kwegomarara anogona kusashanda kune wese murwere, kukosha uye kuchengetedzeka kana mabhenefiti eAshitaba anosiyana zvichienderana nemamiriro emunhu. Zvinhu zvakadai semhando chaiyo yegomarara, genetic predispositions, marapirwo azvino, mamwe ma supplements ari kutorwa, mararamiro, BMI, uye chero allergies zvese zvine basa mukuona kana Ashitaba yakakodzera kana kudziviswa, zvichisimbisa kukosha kwekufunga kwemunhu zvisarudzo zvakadaro.

1. Ko Ashitaba Supplements ichabatsira Primary Paget chirwere chezamu Varwere vari kurapwa Letrozole?

Chirwere chePaget chezamu chinoratidzwa nekumwe kushanduka kwemajini, zvinoti TTN, MUC22 uye CCDC168, izvo zvinotungamirira kuchinjwa kwemararamiro emakemikari nzira, kunyanya PI3K-AKT-MTOR Signaling. Kubudirira kwekurapwa kwegomarara, senge Letrozole, kunoenderana nemaitiro ayo ekuita pane idzi nzira dzakananga. Iro zano rakakodzera rinosanganisira kuenzanisa chiito chekurapa nenzira dzinotyaira cancer, nekudaro kuve nechokwadi chemunhu uye nzira inoshanda. Mumamiriro ezvinhu akadai, kudzivirira chikafu kana kudya kunovaka muviri kunogona kupokana nemhedzisiro yekurapa kana kuderedza kurongeka uku kwakakosha. Semuenzaniso, iyo Ashitaba yekuwedzera, iyo inobata iyo PI3K-AKT-MTOR Signaling, inogona kunge isiri iyo sarudzo yakanaka munyaya yePrimary Paget chirwere chezamu kana ichiitwa Letrozole. Izvi zvinodaro nekuti zvinogona kuwedzera kufambira mberi kwechirwere kana kukanganisa kushanda kwekurapa. Pakusarudza chirongwa chekudya, zvakakosha kuti utarise zvinhu zvakaita serudzi rwegomarara, marapirwo anoenderera mberi, zera, murume kana mukadzi, BMI, mararamiro, uye chero inozivikanwa genetic mutations.

2. Ko Ashitaba Supplements ichabatsira here Primary Penile Squamous Cell Carcinoma Varwere vari kurapwa Mitomycin?

Yekutanga Penile Squamous Cell Carcinoma inotaridzwa neyakajeka genetic mutations, senge ABRAXAS1, PIK3CB uye NUP93, izvo zvinokonzeresa shanduko mubiochemical nzira, kunyanya Lipid Metabolism, Hematopoiesis uye Inositol Phosphate Signaling. Kushanda kwekurapa kenza, seMitomycin, kunotemerwa nekudyidzana kwayo nenzira idzi. Chinangwa ndechekuona kuti kurapwa kunoenderana nemakwara anotyaira cancer, achigonesa nzira yekurapa yemunhu. Muchirevo chechinyorwa chino, zvekudya kana zvekuwedzera zvinowirirana nekurapa kana kuwedzera kurongeka uku kunofanirwa kutariswa. Semuenzaniso, iyo Ashitaba yekuwedzera isarudzo ine musoro kune avo vane Primary Penile Squamous Cell Carcinoma iri pasi peMitomycin. Izvi zvinodaro nekuti Ashitaba inokanganisa nzira dzakadai seLipid Metabolism, iyo inogona kuvharisa zvinhu zvinotyaira Primary Penile Squamous Cell Carcinoma kana kubatsira kushanda kweMitomycin.

3. Ko Ashitaba Supplements Yakachengeteka Kune Vane Hutano Vanhu Vane ATM Mutation Associated Genetic Risk?

Makambani akasiyana-siyana anopa gene mapaneru ekuongorora njodzi yemajini emhando dzakasiyana dzegomarara. Aya mapaneru anosanganisira majini akabatana nezamu, ovarian, uterine, prostate, uye gomarara remudumbu. Kuedza aya majini kunogona kusimbisa kuongororwa uye kuzivisa kurapwa uye manejimendi nzira. Kuziva musiyano unokonzera chirwere kunogona kubatsira mukuyedza uye kuongororwa kwehama dzinogona kunge dziri panjodzi. Iyo ATM gene inowanzo kuverengerwa mune aya mapaneru ekuongorora njodzi yegomarara.

Shanduko muATM gene inokanganisa nzira dzebiochemical kana maitirwo, akadai sePI3K-AKT-MTOR Kuratidzira uye DNA Kugadzirisa, izvo zvinosanganisirwa zvakananga kana zvisina kunanga mukutyaira cancer padanho remamorekuru. Kana genetic panel ikaratidza shanduko muATM yakabatana nenjodzi yakawedzera yeChronic Myelomonocytic Leukemia, chikonzero chesainzi chinoratidza kudzivirira kushandiswa kweAshitaba. Izvi zvinodaro nekuti yekuwedzera Ashitaba inopesvedzera nzira dzakaita sePI3K-AKT-MTOR Chiratidzo, izvo zvinogona kutungamira kune yakaipa mhedzisiro mumamiriro ekuchinja kweATM uye ane chekuita nekenza mamiriro.

4. Ko Ashitaba Supplements Yakachengeteka Kune Vanhu Vane Utano Vane ALK Mutation Associated Genetic Risk?

ALK inoita basa rakakosha mukuongorora njodzi yegomarara. Shanduko muALK inogona kukanganisa nzira dzakakosha dzebiochemical, kusanganisira MAPK Signaling uye Kukura Factor Signaling, iyo inokanganisa kukura kwegomarara. Kana yako genetic panel ikaratidza shanduko muALK yakabatana neCentral Nervous System, funga kuisa Ashitaba supplement muchirongwa chako chekudya. Izvi zvinowedzera zvinogona kupesvedzera nzira dzakaita seMAPK Signaling, kubatsirwa nekupa rutsigiro rwakakodzera kune vanhu vane ALK mutations uye zvine chekuita nehutano.

Mhedziso

Zvinhu zviviri zvakakosha zvekuyeuka ndezvekuti marapirwo egomarara uye chikafu chinovaka muviri hazvina kumbofanana kune wese munhu. Zvokudya zvinovaka muviri, kusanganisira chikafu uye zvekuwedzera seAshitaba, chishandiso chinoshanda chinogona kudzorwa newe uchitarisana negomarara.

"Ndodyei?" ndiwo mubvunzo unonyanya kubvunzwa nevarwere vegomarara uye avo vari panjodzi yegomarara. Mhinduro chaiyo ndeyekuti zvinoenderana nezvinhu zvakaita serudzi rwegomarara, genetics yebundu, marapirwo azvino, allergies, mararamiro, uye BMI.

Tora kudya kwako kwegomarara kubva kuAddon nekudzvanya chinongedzo pazasi uye kupindura mibvunzo nezve rudzi rwegomarara rako, marapirwo, mararamiro, allergies, zera, uye murume kana mukadzi.

References

• cBioPortal yeCancer Genomics
• Anti-inflammatory uye anticholinesterase chiitiko chezvitanhatu zveflavonoids zvakaparadzaniswa kubva kuPolygonum uye Dorstenia marudzi.
• Cancer therapy inoumba kusimba kwenzvimbo ye clonal hematopoiesis.
• Isobavachalcone yakaparadzaniswa kubva kuPsoralea corylifolia inhibits cell proliferation uye inokonzera apoptosis kuburikidza nekudzivisa nzira yeAKT / GSK-3β / β-catenin mumasero emukenza.
• Isobavachalcone inoshandisa anti-proliferative uye pro-apoptotic mhedzisiro pamasero egomarara echiropa chemunhu nekunanga nzira yekusaina ERKs/RSK2.
• Simuka kugomarara chikamu Ib kudzidza kwepan-phosphoinositide-3-kinase inhibitor buparlisib ine letrozole muestrogen receptor-positive/human epidermal growth factor receptor 2-negative metastatic kenza yemazamu.
• [Cyclooxygenase-2 kutaura mune esophageal cancer maseru uye induction ne mitomycin C].